Neovasc Inc. (TSE:NVC – Get Free Report) (NASDAQ:NVCN)’s stock price was up 2.3% during trading on Monday . The stock traded as high as C$1.82 and last traded at C$1.78. Approximately 46,869 shares traded hands during trading, a decline of 58% from the average daily volume of 111,876 shares. The stock had previously closed at C$1.74.
Neovasc Stock Performance
The business has a fifty day moving average of C$1.78.
Neovasc Company Profile
Neovasc Inc (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company’s segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products.
Further Reading
- Five stocks we like better than Neovasc
- There Are Different Types of Stock To Invest In
- Rocket Lab is the Right Stock for the Right Time
- 3 Ways To Invest In Coffee, Other Than Drinking It
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- 10 Best Airline Stocks to Buy
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Neovasc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neovasc and related companies with MarketBeat.com's FREE daily email newsletter.
